JPRN-UMIN000001746已完成2 期
A phase II study of CBDCA and TS-1 in patients with advanced non-small cell lung cancer - A phase II study of CBDCA and TS-1
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pulmonary fibrosis detectable on chest X-ray films 2)Massive pleural effusion, ascites and pericardial effusion required drainage 3)Concomitant malignancy 4)Serious medical complications: uncontrolled angina pectoris, myocardial infarction within 3 months, heart failure. Uncontrolled diabetes mellitus, hypertension, infection (ileus, bleeding, superior vena cava syndrome 5)Symptomatic brain metastasis 6)Pregnant or milk-feeding female. Intention to be pregnant in the future 7)With severe allergy 8)Other clinical difficulties to this study
研究者
相似试验
已完成
1 期
Phase I/II study of TS-1 and CBDCA combination chemotherapy in elderly patients with advanced non-small-cell lung cancerAdvanced non-small-cell lung cancer in elderly patientsJPRN-UMIN000007049The Tokyo Cooperative Oncology Group35
已完成
2 期
A Phase II Clinical Trial of CBDCA and TS-1 concurrent chemotherapy followed by TS-1 Maintenance Therapy for Advanced and Recurrent Squamous Cell Lung Cancer: SMILE Trialon-small cell lung cancer (squamous cell carcinoma)JPRN-UMIN000007242ational Hospital Organization Shikoku Cancer Center30
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
已完成
2 期
Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)Patients with unresectable gastric cancer due to limited inavasion or metastasis.JPRN-UMIN000000934OGSG30
已完成
1 期
Phase I study of TS-1+CDDP+PTX therapy in patients with advanced/recurrent gastric cancer (OGSG 0703)Patients with unresectable or metastatic gastric cancerJPRN-UMIN000000903OGSG6